Latest news
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Biochar triggers long-term soil recovery by reshaping microbes and metabolism
A five-year field study reveals that biochar can do far more than improve soil chemistry. It can reorganize entire soil ecosystems, creating lasting benefits for agriculture and environmental sustainability.
Nipah virus hijacks host protein NSUN2 to fuel replication
Researchers have decoded a critical survival strategy of the deadly Nipah virus (NiV), identifying a key host protein hijacked by the pathogen and translating this discovery into a promising new treatment approach.
Interferon therapy found to be well-tolerated in compensated hepatitis B cirrhosis
A multicenter analysis of 920 patients finds no higher risk of serious complications in compensated cirrhosis compared to standard treatment.
Scientists reveal the potential of a tiny soil bacterium to beat the Haber-Bosch process
A new review finds that biological ammonia production offers strong potential as a cleaner, greener alternative to the costly Haber-Bosch process. Microbes such as Azotobacter can produce ammonia under ambient conditions and atmospheric pressure.
How gossiping mushroom networks share your public urination secrets
Researchers showed evidence of electrical information flow across mushrooms by attaching electrodes to 37 mushrooms of ectomycorrhizal fungi, then measured the response to various applications of either water or urine.
Biochar triggers long-term soil recovery by reshaping microbes and metabolism
A five-year field study reveals that biochar can do far more than improve soil chemistry. It can reorganize entire soil ecosystems, creating lasting benefits for agriculture and environmental sustainability.
Nipah virus hijacks host protein NSUN2 to fuel replication
Researchers have decoded a critical survival strategy of the deadly Nipah virus (NiV), identifying a key host protein hijacked by the pathogen and translating this discovery into a promising new treatment approach.
Interferon therapy found to be well-tolerated in compensated hepatitis B cirrhosis
A multicenter analysis of 920 patients finds no higher risk of serious complications in compensated cirrhosis compared to standard treatment.
Vanderbilt Center for Antibody Therapeutics signs agreement to develop anti-measles antibody treatment
The Vanderbilt Center for Antibody Therapeutics has signed an option agreement with Saravir Biopharma Inc. for the company to develop human monoclonal antibodies isolated in the laboratory of James Crowe Jr., MD, for the treatment and prevention of measles.
Cleanroom specialist Total Clean Air appointed European partner for US-based biodecontamination firm, TOMI
UK-BASED cleanroom engineering company Total Clean Air (TCA), a UKAS ISO 17025-accredited cleanroom constructor, has been appointed European partner for US-based decontamination technology firm TOMI®Environmental Solutions.
EnteroBiotix announces completion of enrolment in Phase 2a Trial evaluating EBX-102-02 prior to allogeneic stem cell transplantation
EnteroBiotix announced that the investigator-initiated Phase 2a MAST trial has completed its enrolment of 50 adult patients undergoing allogeneic haematopoietic stem cell transplantation (allo-HSCT) for defined haematological malignancies.
Virus-inspired DNA needle could pave the way for better medicines
Researchers have developed a microscopic DNA needle that delivers molecules directly into cells and helps keep them active. It may solve a major problem in modern medicine: many therapies are trapped inside cells and lose their effect.
Scientists develop therapeutic, nasally delivered DNA vaccine for tuberculosis
Research shows the vaccine — in combination with drug therapy — accelerated a relapse-free TB cure in mice, improved activity of a drug-resistant TB regimen and stimulated immune responses in nonhuman primates.
Turning algae waste into powerful filters: New biochar membranes clean wastewater more efficiently
A new study has developed a sustainable filtration technology that transforms microalgae waste into high-performance membranes capable of removing pollutants and bacteria from wastewater. The innovation could offer a greener and more efficient solution for municipal water treatment.
Global Virus Network launches expanded “Global Guardians for Pandemic Preparedness” program for Florida high school students
The Global Virus Network (GVN) announced the launch of its expanded Global Guardians for Pandemic Preparedness initiative, with applications now open for high school students across the state of Florida.
Robotics meets genetics: Joining forces to explore Fusarium
Two research groups are bringing together two complementary scientific approaches to discover new antifungal agents – targeting Fusarium, but also those derived from Fusarium.
Call for evidence: Why has the promise of personalised medicine failed to materialise on the ground?
A new inquiry by the UK Parliament’s Science and Technology Committee investigates why the NHS adoption of the UK’s cutting-edge life sciences innovations often fails - and what could be done to fix it. Members of AMI could be just the people to provide answers.